Study Explains How Glucocorticoids Regulate Immunity A human B cell, one of the cell types analyzed in the study. Credit: NIAID New research sheds light on how the human immune system responds to glucocorticoids, a widely used class of immunosuppressive and anti-inflammatory drugs. In the February issue of the Journal of Experimental Medicine, NIAID scientists describe how immune responses to glucocorticoids differ by cell type. This information may aid development of improved therapies that specifically target the cell types of interest for treatment of various diseases, including autoimmune disorders. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107